Skip to main content
Improving antimalarial therapeutic efficacy studies.
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020-22: a two-arm, open-label, cluster-randomised controlled trial.
The inclusion of children and adolescents in tuberculosis diagnostic development and evaluation-a consensus statement.
The emergence of artemisinin partial resistance in Africa: how do we respond?
Advancing detection and response capacities for emerging and re-emerging pathogens in Africa.
Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis.
Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study.
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' reply.
Has artemisinin resistance emerged in Africa?